Bioservo Technologies AB Interim Report January – June 2023
April-June in figures · Net sales of 1.2 MSEK (3.6) · EBITDA of -11.4 MSEK (-11.0) · EBIT of -11.9 MSEK (-11.8) · Earnings for the period amounted to -11.9 MSEK (-11.8) · Earnings per share before and after dilution amounted to SEK -0.42 (-0.62) · Cash flow from operating activities for the period amounted to – 9.5 MSEK (-9.8) January-June in figures · Net sales of 5.8 MSEK (6.5) · EBITDA of -20.3 MSEK (-21.8) · EBIT of -21.3 MSEK (-23.9) · Earnings for the period amounted to -21.3 MSEK (-23.9) · Earnings per share before and after dilution amounted